Michael J. Martens - Concepedia

Author

Michael J. Martens

Also Known As

M. Martens, MICHAEL MÄRTENS, Martens, Michael, Martens, Michael J., Michael J Martens, Michael J. Martens, Michael Martens, Michael Märtens

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Medical College of Wisconsin Fred Hutch Cancer Center Moffitt Cancer Center Dana-Farber Cancer Institute Emmes (United States)

About

Michael J. Martens is an author at Medical College of Wisconsin specializing in medicine, transplantation, and blood transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	118
2	Blood Transplantation	5	5	94
3	Health Sciences	2	2	37
4	Public Health	1	1	18
5	Cellular Therapies	1	1	16

Michael J. Martens

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis Javier Bolaños‐Meade, Mehdi Hamadani, Juan Wu, New England Journal of Medicine	2023	460
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States Lori Muffly, Marcelo C. Pasquini, Michael J. Martens, Blood	2017	281
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome Ryotaro Nakamura, Wael Saber, Michael J. Martens, Journal of Clinical Oncology	2021	133
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial Joseph Pidala, Mehdi Hamadani, Peter Dawson, Blood	2019	81
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study Jurjen Versluis, Wael Saber, Harrison Tsai, Journal of Clinical Oncology	2023	58
Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703 Shernan G. Holtan, Mehdi Hamadani, Juan Wu, Blood	2022	52
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial Jennifer M. Knight, Karen L. Syrjala, Navneet S. Majhail, Biology of Blood and Marrow Transplantation	2016	31
Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation Joseph Pidala, Michael J. Martens, Claudio Anasetti, JAMA Oncology	2019	31
Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia Eric Segal, Michael J. Martens, Hailin Wang, Cancer	2017	30
Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study Ran Reshef, Wael Saber, Javier Bolaños‐Meade, Journal of Clinical Oncology	2021	30

Page 1